Guardant Health, Inc.GHNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank78
3Y CAGR-0.9%
5Y CAGR+19.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-0.9%/yr
vs +64.8%/yr prior
5Y CAGR
+19.4%/yr
Recent deceleration
Acceleration
-65.6pp
Decelerating
Percentile
P78
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$364.19M+4.7%
2024$347.75M-5.3%
2023$367.19M-1.8%
2022$373.81M+42.0%
2021$263.22M+75.6%
2020$149.86M+73.7%
2019$86.29M+70.2%
2018$50.71M+98.4%
2017$25.56M+135.4%
2016$10.86M-